Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase.
Article Details
- CitationCopy to clipboard
Hornemann T, Richard S, Rutti MF, Wei Y, von Eckardstein A
Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase.
J Biol Chem. 2006 Dec 8;281(49):37275-81. Epub 2006 Oct 4.
- PubMed ID
- 17023427 [ View in PubMed]
- Abstract
Serine-palmitoyltransferase (SPT) catalyzes the rate-limiting step of the de novo synthesis of sphingolipids. SPT is considered to be a heterodimer composed of two subunits, SPTLC1 and SPTLC2. Here we report the identification of a novel, third, SPT subunit (SPTLC3) that shows 68% homology to the SPTLC2 subunit. Quantitative real-time PCR revealed that SPTLC3 expression is highly variable between different human tissues and cell lines. The highest expression was observed in placenta tissue and human trophoblast cell lines. The overexpression of SPTLC3 in Hek293 cells, which otherwise have very little endogenous SPTLC3, led to a 2- to 3-fold increase in cellular SPT activity. Silencing of SPTLC3 expression in HepG2 cells or human trophoblast cells by transfecting SPTLC3-specific siRNA resulted in a significant reduction of cellular SPT activity. The expression of two SPT isoforms could be a cellular mechanism to adjust SPT activity to tissue-specific requirements of sphingolipid synthesis.